Cargando…
New technologies and Amyotrophic Lateral Sclerosis – Which step forward rushed by the COVID-19 pandemic?
Amyotrophic Lateral Sclerosis (ALS) is a fast-progressive neurodegenerative disease leading to progressive physical immobility with usually normal or mild cognitive and/or behavioural involvement. Many patients are relatively young, instructed, sensitive to new technologies, and professionally activ...
Autores principales: | Pinto, Susana, Quintarelli, Stefano, Silani, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403097/ https://www.ncbi.nlm.nih.gov/pubmed/32882437 http://dx.doi.org/10.1016/j.jns.2020.117081 |
Ejemplares similares
-
Amyotrophic lateral sclerosis: applications of stem cells – an update
por: Cova, Lidia, et al.
Publicado: (2010) -
Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
por: Verde, Federico, et al.
Publicado: (2021) -
Exosome microRNAs in Amyotrophic Lateral Sclerosis: A Pilot Study
por: Pregnolato, Francesca, et al.
Publicado: (2021) -
Correlation between clinical phenotype and electromyographic parameters in amyotrophic lateral sclerosis
por: Colombo, Eleonora, et al.
Publicado: (2022) -
Regional spreading pattern is associated with clinical phenotype in amyotrophic lateral sclerosis
por: Maranzano, Alessio, et al.
Publicado: (2023)